DNMT3B 579G>T Promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a chinese population

Acta Haematologica

Volumn 122, Issue 1, 2009, Pages 31-35

  Zhao, Haifeng ^a   Du, Weiting ^a   Gu, Dongsheng ^a   Wang, Donghai ^b   Xue, Feng ^a   Ge, Jing ^a   Sui, Tao ^a   Yang, Renchi ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

DNA methyltransferase 3B; Idiopathic thrombocytopenic purpura; Polymorphism

Indexed keywords

DNA METHYLTRANSFERASE 3B;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CHILD; CHINESE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; DNA POLYMORPHISM; ENZYME ACTIVITY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHINA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 68949128784     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235616     Document Type: Article

References (27)

1. Yang R, Han ZC: Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update. Int J Hematol 2000; 71: 18-24.
2. Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995-1008.
3. Cooper N, Bussel J: The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 2006; 133: 364-374.
4. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-2393.
5. Wilson CB, Makar KW, Shnyreva M, Fitzpatrick DR: DNA methylation and the expanding epigenetics of t cell lineage commitment. Semin Immunol 2005; 17: 105-119.
6. Fitzpatrick DR, Wilson CB: Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 2003; 109: 37-45.
7. Smale ST, Fisher AG: Chromatin structure and gene regulation in the immune system. Annu Rev Immunol 2002; 20: 427-462.
8. Luczak MW, Jagodzinski PP: The role of DNA methylation in cancer development. Folia Histochem Cytobiol 2006; 44: 143-154.
9. Turek-Plewa J, Jagodzinski PP: The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005; 10: 631-647.
10. Hermann A, Gowher H, Jeltsch A: Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004; 61: 2571-2587.
11. Clarke LE, Leitzel K, Smith J, Ali SM, Lipton A: Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RTPCR. Int J Oncol 2003; 22: 425-430.
12. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H: Expression of DNA methyltransferases DNMT1, 3a, and 3b in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001; 97: 1172-1179.
13. Nagai M, Nakamura A, Makino R, Mitamura K: Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol Res 2003; 26: 186-191.
14. Patra SK, Patra A, Zhao H, Dahiya R: DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 2002; 33: 163-171.
15. Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S: Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003; 105: 527-532.
16. Yakushiji T, Uzawa K, Shibahara T, Noma H, Tanzawa H: Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 2003; 22: 1201-1207.
17. Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez- Lostao L, Rosa-Leyva M, Vilardell- Tarres M: Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology 2008; 124: 339-347.
18. Wang J, Walsh G, Liu DD, Lee JJ, Mao L: Expression of DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer. Cancer Res 2006; 66: 8361-8366.
19. Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA: Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 2006; 27: 1661-1669.
20. Montgomery KG, Liu MC, Eccles DM, Campbell IG: The DNMT3B C- 1 T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 2004; 6:R390-R394.
21. Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q: A novel polymorphism in human cytosine DNA-methyltransferase-3b promoter is associated with an increased risk of lung cancer. Cancer Res 2002; 62: 4992-4995.
22. Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Cho YL, Jung TH, Park JY: DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2005; 26: 403-409.
23. Tao J, Yang M, Chen Z, Huang Y, Zhao Q, Xu J, Ren H, Zhao H, Chen Z, Ren Q, Yang R: Decreased DNA methyltransferase 3a and 3b mRNA expression in peripheral blood mononuclear cells and increased plasma SAH concentration in adult patients with idiopathic thrombocytopenic purpura. J Clin Immunol 2008; 28: 432-439.
24. Hong YS, Lee HJ, You CH, Roh MS, Kwak JY, Lee MJ, Kim JY: DNMT3b 39179GT polymorphism and the risk of adenocarcinoma of the colon in Koreans. Biochem Genet 2007; 45: 155-163.
25. Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM: DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 2008; 17: 330-338.
26. Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, Hanash SM, Richardson BC: Decreased RAS-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001; 44: 397-407.
27. Chang KP, Hao SP, Liu CT, Cheng MH, Chang YL, Lee YS, Wang TH, Tsai CN: Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Oral Oncol 2007; 43: 345-351.